1.      Pirinccioglu AG, Deniz T, Gokalp D, Beyazit N, Haspolat K, Soker M. Assessment of thyroid function in children aged 1-13 years with Beta-thalassemia major. Iran J Pediatr. 2011;21(1):77-82.

2.      Garadah TS, Mahdi NA, Jaradat AM, Hasan ZA, Nagalla DS. Thyroid function status and echocardiographic abnormalities in patients with Beta thalassemia major in Bahrain. Clin Med Insights Cardiol. 2013;7:21-27.

3.      Shitrit D, Tamary H, Koren A, Levin C, Bargil-Shitrit A, Sulkes J, Kramer MR. Correlation of vascular endothelial growth factor with the severity of thalassemia intermedia. Blood Coagul Fibrinolysis. 2008;19(7):611-614.

4.      Johnson, K.E., and Wilgus, T.A. Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair. Advances in Wound Care. 2014;3(10):647-661.

5.      Palmer, Biff F.; Clegg, Deborah J. Oxygen sensing and metabolic homeostasis. Molecular and Cellular Endocrinology. 2014;397(1-2):51–58.

6.      Dunst J, Becker A, Lautenschläger C, Markau S, Becker H, Fischer K, Haensgen G. Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF). Strahlenther Onkol. 2002;178 (8):436-441.

7.      Kanavaki I, Makrythanasis P, Lazaropoulou C, Tsironi M, Kattamis A, Rombos I, Papassotiriou I. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia. Blood Cells Mol Dis. 2009;43(3):230-234.

8.      Aggeli C, Antoniades C, Cosma C, Chrysohoou C, Tousoulis D, Ladis V, Karageorga M, Pitsavos C, Stefanadis C. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol. 2005;105(1):80-84.

9.      Birk DM, Barbato J, Mureebe L, Chaer RA. Current insights on the biology and clinical aspects of VEGF regulation. Vasc Endovascular Surg. 2009;42(6):517-530.

10.  Karamysheva A.F. Mechanisms of Angiogenesis. Biochemistry (Moscow). 2008;73(7):751-762.

11.  De Sanctis V, Soliman AT, Elsedfy H, Skordis N, Kattamis C, Angastiniotis M, Karimi M, Yassin MM, El Awwa A, Stoeva I, Raiola G, Galati MC, Bedair EM, Fiscina B, El Kholy M. Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines. Indian J EndocrinolMetab. 2013;17(1):8–18.

12.  Elsayh KI, Mohammed WS, Zahran AM, Saad K. Leukocytes apoptosis and adipocytokines in children with beta thalassemia major. ClinExp Med. 2016;16(3):345-350.

13.  Chaudhary HT, Ahmad N. Frequency of platelet aggregation defects in children suffering fromg β-thalassemia. Saudi J Health Sci. 2012;1(2):92-98.

14.  Shahramian I, Razzaghian M, Ramazani AA, Ahmadi GA, Noori NM, Rezae AR. The Correlation between Troponin and Ferritin Serum Levels in the Patients with Major Beta-Thalassemia. IntCardiovasc Res J. 2013;7(2):51–55.

15.  Farokhi F, Razaviyan J, kosaryan M, Roudbari M, Reykande SE, Aliasghariyan A, Dehghani M . The relationship between serum vascular endothelial growth factor (SVEGF) and beta thalassemia major. Int J Med Invest. 2015;4(3):289-292.

16.  Fahmey SS, Naguib HF, Abdelshafy SS, Alashry RE. Vascular endothelial growth factor in children with thalassemia major. Mediterr J Hematol Infect Dis. 2013;5(1):p.2013044.

17.  Olgar S, Kara A, Hicyilmaz H, Balta N, Canatan D. Evaluation of angiogenesis with vascular endothelial growth factor in patients. Pediatr Int. 2010;52(2):247-251.

18.  Blann A.D., Mohan J.S., Bareford D. and Lip G. Soluble P- selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype. J. Thromb Thrombolysis. 2008;25(2):185–189.

19.  Silha J.V., Krsek M., Sucharda P. and Murphy L.J. Angiogenic factors are elevated in overweight and obese individuals. Int. J. Obes. (Lond). 2005;29(11):1308-1314.